Mutant IDH1 Inhibitor Olutasidenib
1 clinical trials · Condition
◉ Watch Mutant IDH1 Inhibitor Olutasidenib
| Record | Firm | Date |
|---|---|---|
| Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib (NCT06445959) | M.D. Anderson Cancer Center | 2024-08-29 |
Track Mutant IDH1 Inhibitor Olutasidenib automatically
Every clearance here is in the API, with alerts when new ones post.